Milt nasal drops is a combination preparation containing phenylephrine and dimethindene.
The preparation reduces nasal discharge and helps to cleanse the nasal passages without disturbing the physiological functions of the ciliated epithelium and nasal mucosa.
Phenylephrine belongs to the sympathomimetic amines. It is used as a nasal decongestant with a moderate vasoconstrictor effect, selectively stimulates the α1-adrenergic receptors of the cavernous venous tissue of the nasal mucosa. Thus, it quickly and permanently eliminates the swelling of the nasal mucosa and its paranasal sinuses.
Dimetindene is an antagonist of histamine H1 receptors, has antiallergic effect. Effective when used in low doses, well tolerated.
In adults and children over 2 years old:
Preparation for surgery in the nasal area, and elimination of edema of the nasal mucosa and paranasal sinuses after surgery.
Hypersensitivity to phenylephrine, dimethindene maleate or any excipients.
Due to the content of phenylephrine, the preparation, like other vasoconstrictors, is contraindicated in atrophic rhinitis, angle-closure glaucoma, as well as in patients taking monoamine oxidase inhibitors (MAO) or taking them for the previous 14 days.
Before administering the preparation, you should thoroughly clean the nose. The patient should tilt his head back when sitting or standing, or to the side if he is lying in bed. After instilling the drops, it is advisable to leave the head tilted for a few minutes to allow the preparation to spread in the nasal cavity.
The dropper cap should be washed and dried before screwing onto the vial.
Children from 2 to 6 years old: 1-2 drops in each nasal passage 3-4 times a day.
Children from 6 years old and adults: 3-4 drops in each nasal passage 3-4 times a day.
The period of continuous treatment should not exceed 3 days and depends on the course of the disease. The use of the preparation in children from 2 to 12 years old should be carried out under the supervision of adults.
In case of an overdose, the preparation Milt nasal drops can cause such sympathomimetic and anticholinergic effects as increased heartbeat, premature contraction of the ventricles of the heart, pain in the back of the head, tremors or tremors, mild tachycardia, high blood pressure, mydriasis, numbness, agitation, hallucinations, insomnia and convulsions, pallor. An overdose of the preparation can cause moderate sedation, increased fatigue, coma, stomach pain, nausea, vomiting.
There were no serious side effects reported after accidental use of the preparation. Accidental ingestion of doses of dimetindene up to 20 mg into the gastrointestinal tract did not lead to severe symptoms.
Treatment: the use of activated carbon, possibly laxatives for young children (gastric lavage is not required); adults and older children are prescribed plenty of fluids.
Phenylephrine-induced hypertension, which exhibits an inadequate response to benzodiazepines, can be treated with an α-adrenergic blocker. Central anticholinergic symptoms can be treated with physostigmine. It is advisable to consult a doctor regarding the use of antidotes. Since there are no data on the ingestion of doses of dimetindene more than 20 mg into the gastrointestinal tract, patients with significant overdose are shown medical supervision and, if a doctor prescribes, a single dose of activated carbon. Severe agitation and seizures should be treated with benzodiazepines.
Application during pregnancy or lactation.
Studies of the use of phenylephrine and dimethindene maleate during pregnancy or lactation have not been conducted. Given the potential systemic vasoconstrictor effect of phenylephrine, it is recommended to refrain from using the preparation during pregnancy.
It is recommended to refrain from using the preparation during breastfeeding.
Fertility
There is a lack of adequate data on the effects of phenylephrine and dimethindene maleate on human fertility.
The ability to influence the reaction rate when driving or driving other mechanisms
No data available.
Children
This preparation is not recommended for use in children under 2 years of age.
Active ingredients: phenylephrine, dimethindene maleate.
1 ml of the preparation contains:
phenylephrine - 2.5 mg
dimethindene maleate - 0.25 mg
Excipients: benzalkonium chloride; lavender extract; sorbitol (E 420); citric acid, monohydrate; sodium hydrogen phosphate, dodecahydrate; water for injections.
Store in its original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Shelf life is 2 years. The shelf life after opening the bottle is 4 months.
Do not use the preparation after the expiration date indicated on the package.
There are no reviews for this product.